A key distinction in our study is its focus on the relationship between the EMT and galectin-3; thus, staining was assessed primarily in invasive tumor areas with pronounced tumor budding, while expressions in superficial non-invasive tumor regions were excluded from scoring. Here, LGALS3 is linked to neoplasm.